Results 181 to 190 of about 358,448 (349)
Dupilumab Beyond the Airway: Decreased Morbidity in a Real‐World Analysis
ABSTRACT Background Post hoc analyses of clinical trials have characterized dupilumab's adverse effects, yet the real‐world impact in chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma is not well described. This study aims to characterize the risks of lymphoma, cardiovascular events, eosinophilia, joint pain, inflammatory arthritis, and ...
Emma J. Anisman +9 more
wiley +1 more source
Economic evaluation of cognitive behavioral rehabilitation for chronic musculoskeletal pain
Mariëlle E. J. B. Goossens
openalex +2 more sources
Establishment of a biosafe murine model of skeletal tuberculosis using Mycobacterium smegmatis
This study developed a biosafe, accessible, and versatile murine model of bone TB using Mycobacterium smegmatis, a fast‐growing, nonpathogenic mycobacterial species with high genomic homology to Mycobacterium tuberculosis. Three infection routes—subperiosteal calvarial injection, intratibial injection, and intracardiac (left ventricular) inoculation ...
Yewei Jia +12 more
wiley +1 more source
Exercise for chronic musculoskeletal pain: time to prescribe with precision. [PDF]
Arora NK +10 more
europepmc +1 more source
Multimorbidity and animal models
Multimorbidity, defined as the coexistence of ≥2 chronic conditions, is associated with aging, genetics, and environmental factors. Animal models in multimorbidity research span three tiers: simple organisms for initial screening → rodents for mechanistic analysis → large mammals for clinical prediction.
Xinpei Wang +7 more
wiley +1 more source
Assessment of Risk Factors for Musculoskeletal Pain Among University Staff Members. [PDF]
Mortada EM +4 more
europepmc +1 more source
Prevalence of work-related musculoskeletal pain among neurosurgeons and trainees in the Philippines [PDF]
Sean Kendrich +4 more
openalex +1 more source
Trametinib in Adults with Neurofibromatosis Type 1‐Related Symptomatic Plexiform Neurofibromas
Objective Mitogen‐activated protein kinase kinase inhibitors have shown promising results in treatment of plexiform neurofibromas in neurofibromatosis type 1 patients, but data in adults are limited. The aim of this phase 2 study was to investigate the efficacy and safety of trametinib in adults with neurofibromatosis type 1.
D. Christine Noordhoek +7 more
wiley +1 more source

